These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7178594)

  • 1. [Corticoids and selective beta 2-agonists: spirometric synergism and oxymetric antagonism].
    Díez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascón F; de Portugal Alvarez J
    Rev Clin Esp; 1982 Oct; 167(2):113-6. PubMed ID: 7178594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchodilation effects of aminophylline, fenoterol and their combination].
    Mayer M; Dúbravová H
    Bratisl Lek Listy; 1982 Sep; 78(3):323-33. PubMed ID: 7139383
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obstructive respiratory diseases. Comparisons of dose effectiveness of Fenoterol (Berotec) given in diverse oral administration forms].
    Hertwig B
    ZFA (Stuttgart); 1979 Jan; 55(2):113-22. PubMed ID: 425634
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled aerosol comparison of two inhalations of ibuterol with two of fenoterol.
    Minette A; Marco M
    Acta Tuberc Pneumol Belg; 1978; 69(2):99-106. PubMed ID: 747144
    [No Abstract]   [Full Text] [Related]  

  • 5. Pressurized bronchodilator aerosol technique: influence of breath-holding time and relationship of inhaler to the mouth.
    Lawford P; McKenzie
    Br J Dis Chest; 1982 Jul; 76(3):229-33. PubMed ID: 7126435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of bronchial obstruction with a combination of a selective beta adrenergic (fenoterol) and a cholinolytic agent (ipratropium)].
    Vondra V; Prazáková J; Felkel H; Tomíska F
    Vnitr Lek; 1981 Nov; 27(11):1078-85. PubMed ID: 6458940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of a pressurized aerosol inhaler with an elongated mouthpiece].
    Barliński J; Doboszyńska A; Droszcz W; Kowalski J
    Pol Arch Med Wewn; 1983; 70(1-2):13-6. PubMed ID: 6359087
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient errors and preference with regard to the use of a bronchodilating spray and fenoterol (Berotec) powder.
    Kornstad S; Boye NP
    Eur J Respir Dis Suppl; 1983; 130():12-6. PubMed ID: 6581056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The TAO-methylprednisolone combination in chronic obstructive bronchopneumopathy. Clinical, metabolic and hormonal aspects].
    Logroscino CD; Maringelli D; Losito G; Tota N
    G Ital Chemioter; 1982; 29(2):133-8. PubMed ID: 6985282
    [No Abstract]   [Full Text] [Related]  

  • 11. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the acid-base status of pregnant women treated with partusisten and trometamol].
    Atanasov B; Smilov I; Mitev L
    Akush Ginekol (Sofiia); 1982; 21(2):119-24. PubMed ID: 7125111
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the bronchospasmolytic action of fenoterol and iprafen].
    De Maria C; Casazza G
    Arch Monaldi; 1984; 39(3):223-5. PubMed ID: 6242134
    [No Abstract]   [Full Text] [Related]  

  • 14. Modifying delivery technique of Fenoterol from a metered dose inhaler.
    Newhouse MT; Dolovich M; Dolovich J
    Ann Allergy; 1984 Dec; 53(6):496-8. PubMed ID: 6507953
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-response study of oral fenoterol in asthmatic children.
    Gurwitz D; Levison H
    Dev Pharmacol Ther; 1980; 1(5):265-73. PubMed ID: 7438972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

  • 17. The site of action of a beta 2-receptor stimulating drug (Fenoterol) on antigen-induced bronchoconstriction.
    Zimmermann I; Bugalho de Almeida AA; Ulmer WT
    Lung; 1980; 158(1):15-23. PubMed ID: 6105230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
    Iaia E; Cagnazzo R; Digilio VS; Scoditti A
    Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs of choice in obstructive respiratory tract diseases. Prof. Dr. med. Dr. h. c. W. T. Ulmer, Bochum, establishes the role of modern beta 2-sympathomimetic drugs and the possibility for new aerosol technics].
    Ulmer WT
    Fortschr Med; 1989 Mar; 107(8):51. PubMed ID: 2707711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrocardiogram changes in pregnant women during tocolysis with the beta-adrenomimetics, Partusisten and Pre-Par].
    Ivanov S; Tsankov Ts
    Akush Ginekol (Sofiia); 1980; 19(5-6):423-7. PubMed ID: 7224045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.